U.S. Markets closed

ImmunoGen, Inc. (IMGN) Catches Eye: Stock Jumps 6.3%

Zacks Equity Research

ImmunoGen, Inc. (IMGN) was a big mover last session, as the company saw its shares rise a little over 6% on the day. This jump can be attributable to solid volume too with far more shares changing hands than in a normal session. This broke the recent trend of the company, as the stock is now trading above the volatile price range of $14.33 to $16.12 in the past one-month time frame.

The company has seen 8 positive revisions in the past few weeks, while its Zacks Consensus Estimate of a loss narrowed over the same period, suggesting that more solid trading could be ahead for ImmunoGen. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

ImmunoGen, Inc currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Some better-ranked stocks in the healthcare industry include Alexion Pharmaceuticals, Inc. (ALXN), Biogen Idec Inc. (BIIB) and Cambrex Corporation.(CBM). All these stocks hold a Zacks Rank #1 (Strong Buy).  

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

IMMUNOGEN INC (IMGN): Free Stock Analysis Report


BIOGEN IDEC INC (BIIB): Free Stock Analysis Report

CAMBREX CORP (CBM): Free Stock Analysis Report

Zacks Investment Research